论文信息 - A phase III randomised trial of LV 5 FU 2 1 irinotecan versus LV 5 FU 2 alone in adjuvant high-risk colon cancer ( FNCLCC Accord 02 / FFCD 9802 ) - 字舞流文

A phase III randomised trial of LV 5 FU 2 1 irinotecan versus LV 5 FU 2 alone in adjuvant high-risk colon cancer ( FNCLCC Accord 02 / FFCD 9802 )

T. Conroy | M. Ychou | M. Ducreux | J. Douillard | Y. Bécouarn | O. Bouché | S. Gourgou-Bourgade | L. Mineur | A. Kramar | J. Raoul | J. Seitz | E. Gamelin | F. Viret | R. Bugat | L. Bedenne